Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Oxford Immunotec Global PLC (NASDAQ: OXFD).

Full DD Report for OXFD

You must become a subscriber to view this report.


Recent News from (NASDAQ: OXFD)

Oxford Immunotec to Present at the 2018 UBS Global Healthcare Conference
OXFORD, United Kingdom and MARLBOROUGH, Mass., May 16, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that Dr. Peter Wrighton-Smith, Chief Executive Officer, will present at the 2018 UBS Global Healthcare Confer...
Source: GlobeNewswire
Date: May, 16 2018 09:00
Oxford Immunotec Global PLC 2018 Q1 - Results - Earnings Call Slides
The following slide deck was published by Oxford Immunotec Global PLC in conjunction with their 2018 Q1 earnings Read more ...
Source: SeekingAlpha
Date: May, 01 2018 13:51
Oxford Immunotec Global's (OXFD) CEO Peter Wrighton-Smith on Q1 2018 Results - Earnings Call Transcript
Oxford Immunotec Global PLC (OXFD) Q1 2018 Earnings Conference Call May 01, 2018 08:00 AM ET Executives Karen Koski - Head of Strategy and Investor Relations Peter Wrighton-Smith - Chief Executive Officer Richard Altieri - Chief Financial Officer Analysts William Quirk - Pi...
Source: SeekingAlpha
Date: May, 01 2018 11:07
Oxford Immunotec Reports First Quarter 2018 Financial Results
OXFORD, United Kingdom and MARLBOROUGH, Mass., May 01, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced first quarter 2018 financial results. “Our first quarter results were in line with our expectations...
Source: GlobeNewswire
Date: May, 01 2018 07:00
Oxford Immunotec Schedules First Quarter 2018 Earnings Release and Conference Call for May 1, 2018
OXFORD, United Kingdom and MARLBOROUGH, Mass., April 17, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that it plans to release first quarter 2018 financial results prior to market open on Tuesday, May 1, 2018....
Source: GlobeNewswire
Date: April, 17 2018 08:30
Factors of Influence in 2018, Key Indicators and Opportunity within U S Concrete, Willis Towers Watson Public, Central European Media Enterprises, ARMOUR Residential REIT, Oxford Immunotec Global, and Siliconware Precision Industries - New Research Emphas
NEW YORK, April 11, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of U S Concrete, Inc. (NASDAQ:USCR), Willis Towers Watson Public Limited Co...
Source: GlobeNewswire
Date: April, 11 2018 07:35
Factors of Influence in 2018, Key Indicators and Opportunity within Marlin Business Services, Oxford Immunotec Global, Teck Resources, Astec Industries, Logitech International S.A, and American Software - New Research Emphasizes Economic Growth
NEW YORK, March 15, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Marlin Business Services Corp. (NASDAQ:MRLN), Oxford Immunotec Global PL...
Source: GlobeNewswire
Date: March, 15 2018 07:35
Oxford Immunotec to Present at Two Upcoming Investor Conferences
OXFORD, United Kingdom and MARLBOROUGH, Mass., March 06, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that Dr. Peter Wrighton-Smith, Chief Executive Officer, is scheduled to present at the following upcoming i...
Source: GlobeNewswire
Date: March, 06 2018 09:00
Oxford Immunotec Announces Appointment of Mark Klausner to the Board of Directors
OXFORD, United Kingdom and MARLBOROUGH, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced the appointment of Mark Klausner to the Company's Board of Directors. Mr. Klausner will also serve as a mem...
Source: GlobeNewswire
Date: March, 01 2018 09:00
Oxford Immunotec Global's (OXFD) CEO Peter Wrighton-Smith on Q4 2017 Results - Earnings Call Transcript
Oxford Immunotec Global PLC (OXFD) Q4 2017 Earnings Conference Call February 27, 2018 08:00 AM ET Executives Karen Koski - Head of Strategy and Investor Relations Peter Wrighton-Smith - Chief Executive Officer Richard Altieri - Chief Financial Officer Analysts Doug Schenkel...
Source: SeekingAlpha
Date: February, 27 2018 14:58

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-1813.5613.5113.7013.4972,096
2018-05-1713.3613.5013.6913.36162,867
2018-05-1613.1513.3713.4413.13166,715
2018-05-1513.3113.1313.3113.0551,978
2018-05-1413.3513.3013.4413.2756,962

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-05-181,7568,59720.4257Cover
2018-05-178,96651,27617.4858Cover
2018-05-164,53923,74619.1148Cover
2018-05-151,29016,1297.9980Cover
2018-05-141,55810,75514.4863Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on OXFD.


About Oxford Immunotec Global PLC (NASDAQ: OXFD)

Logo for Oxford Immunotec Global PLC (NASDAQ: OXFD)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $344,478,133 - 05/11/2018
  • Issue and Outstanding: 25,881,152 - 04/25/2018

 


Recent Filings from (NASDAQ: OXFD)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 01 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 01 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 27 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 12 2018
Filing Type: CT ORDERFiling Source: edgar
Filing Date: April, 03 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 05 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 27 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: February, 27 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 14 2018
Statement of beneficial ownership of common stock by certain persons
Filing Type: SC 13GFiling Source: edgar
Filing Date: February, 14 2018

 

 


Daily Technical Chart for (NASDAQ: OXFD)

Daily Technical Chart for (NASDAQ: OXFD)


Stay tuned for daily updates and more on (NASDAQ: OXFD)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: OXFD)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

Monsta Trader
@MonstaTrader

 

 


Disclaimer: Monsta Trader publishes reports providing information on selected companies. Monsta Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. Monsta Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in OXFD is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Monsta Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. Monsta Trader does not own any shares of OXFD and does not buy, sell, or trade any shares of OXFD. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by Monsta Trader. All rights reserved. Our Full Disclaimer: http://monstatrader.com/disclaimer/